County
Stevens County Emergency Medical Services
The current listed document is more than 24 months old and may be outdated.
Drugs and doses33
A–C Acetaminophen, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Gluconate6
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | page 46 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 46 |
| Seizure | peds | 20 mg/kg | PO | not captured | standing | page 69 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 75 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | page 77 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 40 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 40 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 42 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 42 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 36 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 34 |
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 108 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 34 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 108 |
| Organophosphate poisoning | adult | 1–5 mg | IV | not captured | standing | page 163 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 163 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | page 67 |
| Hyperkalemia | adult | 1–2 g | IV | not captured | standing | page 164 |
D–F Dextrose, Diltiazem, Diphenhydramine, Epinephrine, Fentanyl5
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 59 |
| Hypoglycemia | adult | 25 g | IO | not captured | standing | page 59 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | page 59 |
| Hypoglycemia | peds | 0.5–1 g/kg | IO | not captured | standing | page 59 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 42 |
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 42 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 42 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 48 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 49 |
| Allergic reaction | peds | 1–2 mg/kg | PO | not captured | standing | page 48 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 49 |
| Anaphylaxis | adult | 25–50 mg | PO | not captured | standing | page 48 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 1–2 mg/kg | PO | not captured | standing | page 48 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 49 |
| Dystonic reaction | adult | 25–50 mg | PO | not captured | standing | page 166 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 166 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 48 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV/IO | not captured | standing | page 49 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 76 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IV | not captured | standing | page 76 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 76 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 34 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 40 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 40 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 mcg/kg | IV | not captured | standing | page 37 |
| ACS / chest pain | peds | 1 mcg/kg | IV | not captured | standing | page 37 |
| Mild to moderate pain | adult | 2 mcg/kg | IN | not captured | standing | page 116 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM | not captured | standing | page 116 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 116 |
| RSI induction | adult | 1–3 mcg/kg | IV | not captured | standing | page 107 |
| RSI induction | peds | 1 mcg/kg | IV | not captured | standing | page 107 |
G–L Glucagon, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam6
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV | not captured | standing | page 67 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV | not captured | standing | page 67 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 67 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 67 |
| Cardiogenic shock | adult | 2 mg | IV | not captured | standing | page 35 |
| Hypotension / shock | adult | 2 mg | IV | not captured | standing | page 62 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mL | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 2.5 mL | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 75 |
| COPD | adult | 2.5 mL | NEB | not captured | standing | page 77 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 250 mg | IM | not captured | standing | page 51 |
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 119 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 106 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 116 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 116 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 40 |
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | page 40 |
| Other | adult | 20–50 mg | IO | not captured | standing | page 94 |
| Wide-complex tachycardia | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | page 42 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1–2 mg | IV | not captured | standing | page 68 |
| Agitation | adult | 1–2 mg | IV | not captured | standing | page 173 |
| Agitation | adult | 1–2 mg | IM | not captured | standing | page 173 |
| Agitation | adult | 1–2 mg | IN | not captured | standing | page 173 |
| Eclampsia / pre-eclampsia | adult | 2–4 mg | IV | not captured | standing | page 65 |
| Procedural sedation | adult | 1–2 mg | IV | not captured | standing | page 121 |
| Procedural sedation | adult | 1–2 mg | IM | not captured | standing | page 140 |
| Procedural sedation | peds | 0.1 mg/kg | IV | not captured | standing | page 121 |
| Seizure | adult | 2–4 mg | IV | not captured | standing | page 65 |
| Seizure | adult | 2–4 mg | IM | not captured | standing | page 65 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 65 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | page 65 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV | not captured | standing | page 65 |
| Tricyclic overdose | adult | 2 g | IV | not captured | standing | page 67 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 40 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 49 |
| Anaphylaxis | peds | 1–2 mg/kg | IV | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV | not captured | standing | page 75 |
| COPD | adult | 125 mg | IV | not captured | standing | page 77 |
| Croup | peds | 1–2 mg/kg | IV | not captured | standing | page 79 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | page 79 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 1–2 mg | IV/IM | not captured | standing | page 140 |
| Procedural sedation | adult | 1–5 mg | IV | not captured | standing | page 139 |
| Procedural sedation | peds | 0.5–1 mg | IV | not captured | standing | page 139 |
| RSI induction | adult | 2.5–5 mg | IV/IM | not captured | standing | page 106 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV | not captured | standing | page 37 |
| Mild to moderate pain | adult | 2–10 mg | IV/IO | not captured | standing | page 116 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 116 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5–2 mg | IM | not captured | standing | page 66 |
| Opioid overdose | adult | 0.5–2 mg | IV | not captured | standing | page 66 |
| Opioid overdose | adult | 0.5–2 mg | IO | not captured | standing | page 66 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 36 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 38 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 38 |
| CHF / pulmonary edema | adult | 2 inch | TOP | not captured | standing | page 38 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 176 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mcg | IV/IO | not captured | standing | page 67 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mcg | IV/IO | not captured | standing | page 67 |
| Cardiogenic shock | adult | 2–4 mcg | IV/IO | not captured | standing | page 35 |
| Cardiogenic shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 35 |
| Hypotension / shock | adult | 2–4 mcg | IV/IO | not captured | standing | page 62 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 62 |
| Tricyclic overdose | adult | 2–4 mcg | IV/IO | not captured | standing | page 67 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | page 46 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM/PO | not captured | standing | page 47 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 59 |
P–R Racemic Epinephrine, Rocuronium2
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mL | NEB | not captured | standing | page 49 |
| Anaphylaxis | peds | 0.25–0.5 mL | NEB | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 0.25–0.5 mL | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | adult | 0.25–0.5 mL | NEB | not captured | standing | page 178 |
| Asthma / bronchospasm | peds | 0.25–0.5 mL | NEB | not captured | standing | page 75 |
| Asthma / bronchospasm | peds | 0.25–0.5 mL | NEB | not captured | standing | page 178 |
| Croup | peds | 0.25–0.5 mL | NEB | not captured | standing | page 79 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV | not captured | standing | page 107 |
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 107 |
S–Z Sodium Bicarbonate, Succinylcholine, Thiamine, Tranexamic Acid, Vasopressin5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV | not captured | standing | page 67 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 67 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 67 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 107 |
| RSI induction | peds | 1–2 mg/kg | IV | not captured | standing | page 107 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV | not captured | standing | page 60 |
| Hypoglycemia | adult | 100 mg | IM | not captured | standing | page 60 |
| Hypoglycemia | peds | 25 mg | IV | not captured | standing | page 60 |
| Hypoglycemia | peds | 25 mg | IM | not captured | standing | page 60 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 84 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | standing | page 180 |
Cite this
Stevens County Emergency Medical Services, United States EMS Protocol Census. 145 dose entries, effective 2021-06-01.
https://protoquiz.com/census/agencies/stevens-county-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.